Translational Transplantation Tolerance Cooperative Study Group

Forecasted Federal grant Posted

Opportunity number
RFA-AI-28-010
Agency
Applications expected due
Award size
Not on record

Opportunity facts

Expected posting
Assistance listings
Funding instrument
Cooperative Agreement
Category
  • Health
Eligible applicants
  • Public or Indian Housing Auth.
  • State Governments
  • Higher Education Inst. (Private)
  • Other
  • Tribal Organizations (Not Federally Recognized)
  • Higher Education Inst. (Public)
  • 501(c)(3) Nonprofits
  • Independent School Districts
  • Small Businesses
  • City/Township Governments
  • Special District Governments
  • For Profit Organizations
  • Non-501(c)(3) Nonprofits
  • Tribal Governments (Federally Recognized)
  • County Governments
Points of contact

Opportunity details come from Grants.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) is forecasting a cooperative agreement to establish the Translational Transplantation Tolerance Cooperative Study Group (TTTCSG), a multi-center program dedicated to developing, optimizing, and evaluating approaches to induce and maintain immune tolerance to allogeneic transplants in translationally relevant models, with the goal of achieving long-term graft survival without life-long immunosuppressive drug administration. This is a forecast announcement with no application deadline specified.

Eligible applicants include public and private higher education institutions, 501(c)(3) and non-501(c)(3) nonprofits, state and local governments, tribal governments (federally recognized and other than federally recognized), special district governments, Indian housing authorities, independent school districts, small businesses, for-profit organizations, federal agencies, U.S. territories or possessions, faith-based or community-based organizations, and regional organizations.

The program operates under CFDA 93.855 (Allergy and Infectious Diseases Research) and is authorized by Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and 42 CFR Part 52 and 2 CFR Part 200. Award amount, number of awards, and period of performance are not specified in this forecast. The program's scientific review will assess scientific merit and general significance of proposed objectives, technical adequacy of experimental design and approach, investigator competency, adequacy of facilities and resources, budget necessity relative to proposed work, and relevance to announced program objectives. Standard NIH record retention (three years from final FSR submission) and audit requirements apply.

Forecast synopsis

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the support of the Translational Transplantation Tolerance Cooperative Study Group (TTTCSG) program. The overarching goal of this program is to facilitate clinical translation of safe and effective transplant tolerance regimens that achieve long-term graft survival without the need for life-long administration of immunosuppressive drugs. This program will enable establishment of a multi-center, cooperative program dedicated to developing, optimizing, and evaluating approaches to induce and maintain immune tolerance to allogeneic transplants, which will be tested in translationally relevant models. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity